Author: A. Ant, CADC-II, Licensing & Accreditation Expert
Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.
Apply now: BHA License Application Packet | Questions: (360) 236-4700
A residential SUD program in Washington operates under a Behavioral Health Agency (BHA) license certified for residential treatment, plus a residential treatment facility (RTF) license for the building, both issued by the Washington State Department of Health (DOH). Get the certification wrong, or skip the deemed-status conversation entirely, and you’re either building toward the wrong scope of service or leaving a real inspection benefit on the table.
The Residential Certification, and What It Actually Covers
On the program side, Washington doesn’t issue a separate “residential SUD license.” Your core BHA license is certified for residential treatment under WAC 246-341, alongside whatever other certifications your program needs, such as withdrawal management or crisis services. DOH reviews the certification against your actual program design: staffing, physical plant, and clinical protocols specific to residential-level care. The building needs its own license too. Any establishment giving 24-hour on-site care for substance use or mental health treatment is a residential treatment facility under RCW 71.12.455, licensed under WAC 246-337, and DOH’s BHA application asks for a bed count that matches that RTF license.
Correction (October 2026): An earlier version of this guide called the residential service an “endorsement” and described the BHA license as the only license a residential SUD program needs. WAC 246-341-0300 uses the term certification, and a residential program also needs an RTF license under chapter 71.12 RCW and WAC 246-337. The mailing address for applications with a fee has also been corrected to match DOH’s June 2026 application packet.
An initial on-site DOH review is required before a new certification is granted, residential included. This isn’t optional groundwork you can skip by pointing to accreditation you’re still pursuing. DOH needs to see the program operating, or at minimum ready to operate, before it will sign off.
The residential certification on a BHA license describes a type of service. When a referral source wants evidence of a specific ASAM level, 3.5 versus 3.7 for instance, the credential designed for that is CARF’s ASAM Level of Care Certification, offered with ASAM to adult residential programs at Levels 3.1, 3.5 and 3.7. Look for it in CARF’s provider search rather than on DOH paperwork, since it may not appear on the license or certification at all.
Deemed Status Is a Real Advantage Here, Not a Marketing Line
Washington hands its entire ongoing inspection responsibility to the accreditor, which is further than most operators expect this benefit to go. Washington’s deemed-status system, under WAC 246-341-0310 and RCW 71.24.037, means an agency accredited by CARF, The Joint Commission, or the Council on Accreditation can be deemed to meet state standards. For a residential program, where inspection burden tends to be heaviest given the physical plant and staffing complexity involved, this is a genuinely valuable trade. You still complete DOH’s initial on-site review, and deeming can’t waive any state or federal statutory requirement, but the routine inspection cycle that follows becomes your accreditor’s job, not DOH’s.
Programs that pursue accreditation as an afterthought, well after licensure is settled, miss the chance to build both processes around the same documentation and timeline. Sequencing them together from the start is where the real efficiency lives.
Medication-Assisted Treatment in a Residential Setting
Methadone treatment runs through its own opioid treatment program certification on the same BHA license structure described above, so a residential program without that specific certification needs an actual coordination relationship with an OTP-certified provider for any client who needs it, named specifically rather than described as a general referral pathway. Evergreen Treatment Services operates OTP locations across the state, including Seattle, Renton, and Olympia, and WAC 246-341-1108 requires a residential SUD program to offer medication on site or arrange off-site access so a client can keep taking it with no missed doses. In practice that means naming a real partner in your policies, not writing that referrals happen when needed. Buprenorphine is more flexible: any practitioner with a standard DEA registration can prescribe it now that the Consolidated Appropriations Act, 2023 removed the federal waiver requirement, and naltrexone needs only ordinary prescribing privileges.
Build this into your program design early: who can prescribe, what happens if a client arrives already stabilized on methadone or buprenorphine, and how continuity gets documented without a treatment gap.
Where Ketamine Fits in a Washington Residential SUD Program
Washington hasn’t written a ketamine rule for treatment programs. This section lines up the BHA rules, the residential facility and pharmacy licensing statutes, and the nursing board’s sedation guidance, and it reflects our reading of how those pieces connect rather than a DOH determination.
Chapter 246-341 WAC doesn’t bar a residential program from offering ketamine, and it doesn’t address it either. A BHA certification lists behavioral health services such as withdrawal management and residential SUD treatment. A ketamine infusion ordered by a physician or ARNP is a medical act that rests on that clinician’s license, so on the BHA side the work is mostly updated policies and a written heads-up to DOH. The harder Washington question is how the drug gets into the building at all.
Getting Ketamine Into the Building
Washington residential programs hold a residential treatment facility (RTF) license under chapter 246-337 WAC alongside the BHA certification, and the state pharmacy statute, RCW 18.64.011, names residential treatment facilities as one kind of “health care entity.” DOH’s Health Care Entity FAQ says an RTF isn’t required to hold an HCE license. A facility that wants to purchase and stock controlled substances in its own name does need one, with controlled substance authority and a Washington-licensed pharmacist named as pharmacy manager, and only then can it apply to the DEA. The other route DOH describes is having medications obtained through a medical provider who stays responsible for them, which for ketamine means a prescriber holding a DEA registration at the facility’s address. Pick one before the first order is placed. Whichever it is, the RTF’s medication management policies, which WAC 246-337-105 says a health care prescriber and the RTF administrator must develop and approve, need a ketamine section covering storage, counts and waste.
Who Runs the Infusion
The Washington State Board of Nursing, formerly the Nursing Care Quality Assurance Commission, addressed ketamine in its advisory opinion on sedating, analgesic and anesthetic agents (NCAO 7.1, adopted in 2015). That opinion lets a competent RN administer ketamine, but every ketamine use it describes involves pain management. Depression, PTSD and other psychiatric uses never come up. A program planning nurse-run psychiatric infusions should ask the board in writing whether the opinion is still current and whether it reaches that use. The Washington Medical Commission formed a workgroup on psychedelic medications in behavioral health in January 2025, and through its late 2025 meetings it was studying ketamine as a separate topic with no guidance adopted. A quick look at the commission’s site before launch will show whether that has changed.
Staffing is simpler here than in many states. Washington ARNPs practice without a collaborating physician and hold Schedule II through V prescriptive authority, so a psychiatric ARNP already covering the program’s medical care can order the series and stay on site through each session.
Screening Residents With an Addiction History
Some of the people a Washington residential program admits will have used ketamine recreationally, and others will have a history with PCP or whippets, all of which argue against starting a dissociative drug. Ask about each one by name at intake, and if the team goes ahead anyway, write down the reasoning. Ketamine for co-occurring depression or PTSD is off-label, and no form of ketamine is FDA-approved to treat a substance use disorder, so residents shouldn’t hear it described as addiction treatment. The physician PMP check required by WAC 246-919-985 is triggered by opioids and a short list of related drugs, and ketamine isn’t named in it, but pulling the resident’s PMP history at intake is still the fastest way to spot other controlled substances in the picture. Spravato (esketamine nasal spray) follows its own track: a REMS-certified setting and at least two hours of on-site monitoring with pulse oximetry after every dose.
Handing Off to a Stand-Alone Ketamine Clinic
For a resident with an addiction history, the first few sessions are when craving for ketamine itself would surface, and a residential team sees that at the nursing station rather than hearing about it at a follow-up visit. A resident who does well leaves with that record in the chart, and continuing the series after discharge is where many Washington operators look at a separate outpatient ketamine clinic built on a management services organization (MSO) and a professional limited liability company (PLLC).
Washington’s corporate practice of medicine doctrine comes from case law. In Morelli v. Ehsan (1988), the state supreme court held that an unlicensed person can’t share in owning or operating a medical practice, and the courts have held to that line since. The clinic’s licensed side is therefore a PLLC under RCW 25.15.046 or a professional service corporation under chapter 18.100 RCW. Physicians, physician assistants and ARNPs can co-own either one, which gives Washington more room than most strict states, and an ARNP can own the clinic outright. The residential operator or an investor owns the MSO, which leases the space, runs the front office and collects a management fee under a written agreement. The PLLC keeps the DEA registration, the nursing staff and every treatment decision. In the 2026 session, Third Substitute Senate Bill 5387 would have written tight CPOM limits into statute, barring licensed owners of the PLLC from also owning or running the MSO. It cleared Senate Ways and Means in February 2026, then sat in the Senate Rules Committee without a floor vote, so it did not pass before the 2026 session ended. A version may return, so build the management agreement on fair market value and keep clinical control unmistakably with the PLLC.
The referral path between the two businesses needs the most care. The federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220) reaches private insurance and bars paying or receiving anything of value for referrals to a treatment facility or recovery home. A conviction can bring a $200,000 fine and a decade in federal prison. If the residential program falls under 42 CFR Part 2, a resident’s written consent comes first before addiction treatment records reach the clinic, even when both businesses share an owner. Residents should be free to choose a different ketamine provider, and the discharge paperwork should say so. Have healthcare counsel review the arrangement before the first referral goes out.
Staffing a Residential Program
Washington’s SUDPT-to-SUDP pathway is the real lever operators have on residential staffing costs. Residential SUD treatment needs a clinical director, typically a fully credentialed Substance Use Disorder Professional (SUDP), plus enough credentialed staff to match your population’s acuity. Washington’s pathway runs SUDP Trainee (SUDPT) to full SUDP certification, requiring an associate degree or higher (or 90 quarter or 60 semester credits of approved coursework, or an approved apprenticeship), 2,500 supervised hours (reduced with a bachelor’s or master’s degree), and a passing NAADAC or IC&RC exam score.
Round-the-clock residential coverage adds real cost. A residential program with a clinical director, several counselors, and 24-hour direct-care staff commonly runs well past $400,000 a year in payroll before nursing coverage is factored in. It’s a real figure, and Washington’s SUDPT pathway is exactly how operators bring it down. Many Washington residential programs staff a meaningful share of direct-care and counseling roles with SUDPT staff supervised by a single fully credentialed SUDP director, which keeps the program compliant while reducing payroll compared to an all-SUDP roster, and pairs an RN with several LPNs for medical oversight rather than staffing every shift with a registered nurse. Once your census and level of care are known, that specific staffing matrix follows.
How to Submit Your BHA Application
DOH’s Behavioral Health Agency License Application Packet covers residential and inpatient certifications as selectable sections on the same BHA application (an online version is also available). Mail it with your check or money order for the fee to the Department of Health, P.O. Box 1099, Olympia, WA 98507-1099. Documents you send later go to Behavioral Health Agency Licensing, P.O. Box 47877, Olympia, WA 98504-7877. Questions go to (360) 236-4700.
What Delays Washington Residential Applications
Beyond facility buildout, timing the accreditation survey wrong is the other big risk here. The most common delay is starting the CARF or Joint Commission accreditation process too late to actually benefit from deemed status by the time DOH’s initial review happens. The second common issue is applying for a certification scope that doesn’t match the services the program will actually deliver.
Frequently Asked Questions
How long does it take to open a residential SUD program in Washington?
Plan for roughly 12 to 18 months from initial planning to a fully licensed, operating program, driven mostly by facility buildout, staffing readiness, and coordinating an accreditation survey if pursuing deemed status.
Does Washington’s deemed status apply to residential SUD programs specifically?
Yes. Deemed status under WAC 246-341-0310 applies to whatever services the agency is accredited for, residential included, once proof of accreditation is submitted and DOH’s initial on-site review is completed.
Is Certificate of Need a factor for residential SUD programs in Washington?
Generally no. Washington’s active Certificate of Need program mostly targets freestanding psychiatric hospital beds, not community-based residential SUD treatment, though current applicability should be confirmed with DOH for the specific facility type.
Thinking about pursuing deemed status for a Washington residential program? Reach out here.
Sources
- Washington Administrative Code, WAC 246-341-0300: Agency licensure and certification, general information (checked October 8, 2026)
- Washington Administrative Code, WAC 246-341-0310: Agency licensure and certification, deeming (checked October 8, 2026)
- Washington Administrative Code, WAC 246-341-0320: Agency licensure and certification, on-site reviews (checked October 8, 2026)
- Washington Administrative Code, WAC 246-341-1108: Residential and inpatient substance use disorder treatment services (checked October 8, 2026)
- Revised Code of Washington, RCW 71.12.455: Definitions, including residential treatment facility (checked October 8, 2026)
- Revised Code of Washington, chapter 71.12 RCW: Private establishments, including RCW 71.12.460 (checked October 8, 2026)
- Washington Administrative Code, chapter 246-337 WAC: Residential treatment facility (checked October 8, 2026)
- Washington State Department of Health, DOH 611-020 (June 2026): Behavioral Health Agency License Application Packet (checked October 8, 2026)
- Washington State Department of Health: Behavioral Health Agencies, inspection process (checked October 8, 2026)
- Revised Code of Washington, RCW 18.64.011: Pharmacy definitions, including health care entity (checked October 8, 2026)
- Washington State Department of Health: Health Care Entity (HCE) License FAQ (checked October 8, 2026)
- Washington Administrative Code, chapter 246-811 WAC: Substance use disorder professionals and trainees (checked October 8, 2026)
- Washington Administrative Code, WAC 246-919-985: Prescription monitoring program requirements (checked October 8, 2026)
- Washington State Board of Nursing, NCAO 7.1: Administration of Sedating, Analgesic, and Anesthetic Agents (checked October 8, 2026)
- Washington Medical Commission, March 13-14, 2025 meeting packet: January 10, 2025 minutes on the psychedelic medications workgroup (checked October 8, 2026)
- Washington Medical Commission, November 2025 meeting materials: workgroup ketamine discussion (checked October 8, 2026)
- Washington State Board of Nursing: ARNP license and prescriptive authority (checked October 8, 2026)
- U.S. Food and Drug Administration: Spravato prescribing information (checked October 8, 2026)
- Drug Enforcement Administration: Letter on elimination of the DATA-Waiver (checked October 8, 2026)
- Washington State Health Care Authority: Washington State Opioid Treatment Program 2026 Guide (checked October 8, 2026)
- Washington Senate, 1989 Senate Bill Report on SB 5387: discussing Morelli v. Ehsan, 110 Wn.2d 555 (checked October 8, 2026)
- Washington Supreme Court opinion citing Morelli v. Ehsan (1988): opinion text (checked October 8, 2026)
- Revised Code of Washington, RCW 25.15.046: Professional limited liability companies (checked October 8, 2026)
- Revised Code of Washington, chapter 18.100 RCW: Professional service corporations (checked October 8, 2026)
- Washington Legislature, SB 5387 (2025-26): Bill summary and history (checked October 8, 2026)
- Washington Senate, Senate Bill Report on 3SSB 5387 (February 9, 2026): As reported by Ways and Means (checked October 8, 2026)
- U.S. Code, 18 U.S.C. 220: Illegal remunerations for referrals (checked October 8, 2026)
- U.S. Code, 18 U.S.C. 24: Definition of health care benefit program (checked October 8, 2026)
- Code of Federal Regulations, 42 CFR 2.31: Consent requirements (checked October 8, 2026)

Leave a Reply